BCLC Stage C Hepatocellular Carcinoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB09037 | Pembrolizumab | 0 | Terminated | 1 |
| DB11714 | Durvalumab | 1 | Recruiting | 1 |
| DB11771 | Tremelimumab | 1 | Recruiting | 1 |
| DB11595 | Atezolizumab | 2 | Withdrawn | 1 |
| DB08875 | Cabozantinib | 2 | Terminated | 1 |
| DB08875 | Cabozantinib | 2 | Withdrawn | 1 |
| DB14776 | Camrelizumab | 2 | Recruiting | 1 |
| DB11574 | Elbasvir | 2 | Completed | 1 |
| DB15149 | Futibatinib | 2 | Recruiting | 1 |
| DB11575 | Grazoprevir | 2 | Completed | 1 |
| DB06186 | Ipilimumab | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Completed | 1 |
| DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Terminated | 1 |
| DB00811 | Ribavirin | 2 | Completed | 1 |
| DB14765 | Rivoceranib | 2 | Recruiting | 1 |
| DB00398 | Sorafenib | 2 | Completed | 1 |
| DB00398 | Sorafenib | 2 | Recruiting | 1 |
| DB14776 | Camrelizumab | 3 | Recruiting | 1 |
| DB14765 | Rivoceranib | 3 | Recruiting | 1 |
| DB00936 | Salicylic acid | Not Available | Not Yet Recruiting | 1 |